A role for the endocrine and pro-inflammatory mediator MIF in the control of insulin secretion during stress.
The systemic response to injury or infection is often accompanied by significant alterations in host metabolism and glucose homeostasis. Within the liver, these changes include a decrease in glycogenesis and an increase in gluconeogenesis, and in peripheral tissues, the development of insulin resistance and the increased utilization of glucose by non-insulin-dependent pathways. Depending on the severity and the duration of the response, both hyper- and hypoglycemia can ensue and each can become a clinically important manifestation of the systemic inflammatory response. The protein known as macrophage migration inhibitory factor (MIF) has been identified recently to play a central role in host immunity and to regulate glucocorticoid effects on the immune and inflammatory systems. MIF is released in vivo from activated immune cells as well as by the anterior pituitary gland upon stimulation of the hypothalamic-pituitary-adrenal axis. MIF also has been found to be secreted together with insulin from the pancreatic beta-cells and to act as an autocrine factor to stimulate insulin release. Since circulating MIF levels are elevated during stress or systemic inflammatory processes, this protein may play a central role in the control of insulin secretion during various disease states.
Department of Internal Medicine B, University Hospital CHUV, 1011 Lausanne, Switzerland.
G
G
Waeber
T
T
Calandra
C
C
Bonny
R
R
Bucala
D006801:Humans; D007109:Immunity; D007249:Inflammation / Q000503:physiopathology*; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000503:physiopathology*; D008263:Macrophage Migration-Inhibitory Factors / Q000502:physiology*; D013312:Stress, Physiological / Q000503:physiopathology*
D007328:Insulin; D008263:Macrophage Migration-Inhibitory Factors